The involvement of multiple calcium channel sub-types in glutamate release from cerebellar granule cells and its modulation by GABAB receptor activation

doi:10.1016/0306-4522(95)00172-F

Neuroscience

Volume 68, Issue 2, September 1995, Pages 465-478

https://doi.org/10.1016/0306-4522(95)00172-F Get rights and content

Abstract

In this study, we have examined both the ability of various Ca²⁺ channel sub-types to support the release of [³H]glutamate from cerebellar granule neurons and the mechanism of action involved in the modulation of glutamate release by the GABA_B receptor agonist, (−)-baclofen. Cerebellar granule neurons were stimulated to release newly synthesized [³H]glutamate by K⁺-evoked depolarization. Stimulated release was entirely calcium-dependent and abolished by the presence of 200 μM cadmium. Release of glutamate was not affected by either tetrodotoxin or 5-aminophosphonovaleric acid but was potentiated by dihydrokainate and inhibited by 6-cyano-7-nitroquinoxaline-2, 3-dione. Stimulated glutamate release was partially inhibited by both the L-type calcium channel blocker, nicardipine, and the N-type calcium channel blocker, ω-conotoxin GVIA; however, the P/Q-type calcium channel blocker ω-agatoxin IVA inhibited release of glutamate only after pre-incubation of cells with ω-conotoxin GVIA.

K⁺-stimulated release of glutamate was observed when stimulated either in the presence of Ca²⁺ or of Ba²⁺ and similar inhibition of release by (−)-baclofen was seen under both conditions. In contrast to these results, ionomycin-evoked glutamate release was greatly reduced as compared to K⁺-evoked release and was not modulated by (−)-baclofen. In the presence of ω-conotoxin GVIA alone, inhibition of release by (−)-baclofen was attenuated but not abolished. Following block of nicardipine-sensitive channels, inhibition of release by (−)-baclofen was still present, and after prior block of ω-conotoxin GVIA-sensitive channels the presence of nicardipine restored the ability of (−)-baclofen to inhibit residual release of glutamate. Modulation of glutamate release by (−)-baclofen was unaffected by the presence of ω-agatoxin IVA alone; however, after block of both ω-conotoxin GVIA- and ω-agatoxin IVA-sensitive channels, inhibition of release by (−)-baclofen was completely abolished.

These results indicate that multiple sub-types of voltage-dependent calcium channels are present on the presynaptic terminals of cerebellar granule neurons and support K⁺-stimulated release of [³H]glutamate. Modulation of release by GABA_B receptor activation appears to be dependent upon interaction of this receptor with a number of voltage-sensitive calcium channels, including ω-conotoxin GVIA-sensitive and ω-agatoxin IVA-sensitive channels.

Reference (65)

BarhaninJ. et al.
Properties of structure and interaction of the receptor for ω-conotoxin, a polypeptide active on Ca²⁺ channels
Biochem. biophys. Res. Commun.
(1988)
BurkeS.P. et al.
Inhibition of endogenous glutamate release from hippocampal tissue by Ca²⁺ channel toxins
Eur. J. Pharmac.
(1993)
DixonD.B. et al.
Suppression of a Ca²⁺ current by CNQX and kynurenate
Neurosci. Lett.
(1992)
ErecinskaM. et al.
Aspartate transport in synaptosomes from rat brain
J. biol. Chem.
(1983)
ErecinskaM.
The neurotransmitter amino acid transport systems: a fresh outlook on an old problem
Biochem. Pharmac.
(1987)
GrignonS. et al.
ω-Conotoxin sensitive calcium channels in cerebellar granule cells are not coupled to [³H]glutamate release
Neurosci. Lett.
(1993)
HillyardD.R. et al.
A new conus peptide ligand for mammalian pre-synaptic Ca²⁺ channels
Neuron
(1992)
HustonE. et al.
A comparison of the effect of Ca²⁺ channel ligands and GABA_B agonists and antagonists on transmitter release and somatic Ca²⁺ channel currents in cultured neurons
Neuroscience
(1990)
HustonE. et al.
Pertussis toxin treatment increases glutamate release and dihydropyridine binding sites in cultured rat cerebellar granule neurons
Neuroscience
(1993)
KasaiH. et al.
Presynaptic Ca²⁺ antagonist ω-conotoxin irreversibly blocks N-type Ca²⁺ channels in chick sensory neurons
Neurosci. Res.
(1987)

DolphinA.C. et al.

Pertussis toxin reverses adenosine inhibition of neuronal glutamate release

Nature

(1985)

DolphinA.C. et al.

Modulation of voltage dependent calcium channels by GABA_B receptors and G proteins in cultured rat dorsal root ganglion neurons: relevance to transmitter release and its modulation

DolphinA.C.

Voltage-dependent calcium channels and their modulation by neurotransmitters and G-proteins

Expl Physiol.

(1995)

FonnumF.J.

Glutamate, a neurotransmitter in mammalian brain

J. Neurochem.

(1984)

Cited by (54)

Mechanisms of GABA-mediated inhibition of the angiotensin II-induced cytosolic Ca<sup>2+</sup> increase in rat subfornical organ neurons
2021, Brain Research
Neurons in the subfornical organ (SFO) sense both neurotransmitters and circulating humoral factors such as angiotensin II (AII) and atrial natriuretic peptide (ANP), and regulate multiple physiological functions including drinking behavior. We recently reported that AII at nanomolar concentrations induced a persistent [Ca²⁺]_i increase in acutely dissociated SFO neurons and that this effect of AII was reversibly inhibited by GABA. In the present study, we studied the inhibitory mechanism of GABA using Ca²⁺ imaging and patch-clamp electrophysiology. The AII-induced persistent [Ca²⁺]_i increase was inhibited by GABA in more than 90% of AII-responsive neurons and by other two SFO inhibitory ligands, ANP and galanin, in about 60 and 30% of neurons respectively. The inhibition by GABA was mimicked by the GABA_A and GABA_B receptor agonists muscimol and baclofen. The involvement of both GABA receptor subtypes was confirmed by reversal of the GABA-mediated inhibition only when the GABA_A and GABA_B receptors antagonists bicuculline methiodide and CGP55845 were both present. The GABA_B agonist baclofen rapidly and reversibly inhibited voltage-gated Ca²⁺ channel (VGCC) currents recorded in response to depolarizing pulses in voltage-clamp electrophysiology using Ba²⁺ as a charge carrier (I_Ba). Baclofen inhibition of I_Ba was antagonized by CGP55845, confirming GABA_B receptor involvement; was reduced by N-ethylmaleimide, suggesting downstream Gi-mediated actions; and was partially removed by a large prepulse, indicating voltage-dependency. The magnitude of I_Ba inhibition by baclofen was reduced by the application of selective blockers for N-, P/Q-, and L-type VGCCs (ω-conotoxin GVIA, ω-agatoxin IVA, and nifedipine respectively). Overall, our study indicates that GABA inhibition of the AII-induced [Ca²⁺]_i increase is mediated by both GABA_A and GABA_B receptors, and that GABA_B receptors associated with Gi proteins suppress Ca²⁺ entry through VGCCs in SFO neurons.
GABA<inf>B</inf> receptors: modulation of thalamocortical dynamics and synaptic plasticity
2021, Neuroscience
Citation Excerpt :
Both isoforms are found in different locations; GABAB1a are mainly found in presynaptic terminals, where they control neurotransmitter release (Vigot et al., 2006), which depending on the specific type of synapse, excitatory or inhibitory, may inhibit or disinhibit respectively. The presynaptic action of GABAB-Rs inhibiting glutamate release occurs in many areas of the central nervous system (Willcockson et al., 1984; Dutar and Nicoll, 1988; Huston et al., 1995; Emri et al., 1996; Lin et al., 1996) and most probably in all cortical areas (Deisz and Prince, 1989; Kang, 1995; Ramoa and Sur, 1996; Ziakopoulos et al., 2000). GABAB-R-mediated inhibition requires the activation of the adenylyl cyclase/protein kinase A second messenger pathway, through the triggering of Gαi/o-type G proteins and liberation of Gβγ subunits, activating G protein-coupled inward-rectifying K+ channels and inhibition of voltage-gated Ca2+ channels (Bettler et al., 2004) (Figure 1).
GABA_B-receptors (GABA_B-Rs) are metabotropic, G protein-coupled receptors for the neurotransmitter GABA. Their activation induces slow inhibitory control of the neuronal excitability mediated by pre- and postsynaptic inhibition. Presynaptically GABA_B-Rs reduce GABA and glutamate release inhibiting presynaptic Ca²⁺ channels in both inhibitory and excitatory synapses while postsynaptic GABA_B-Rs induce robust slow hyperpolarization by the activation of K⁺ channels. GABA_B-Rs are activated by non-synaptic or volume transmission, which requires high levels of GABA release, either by the simultaneous discharge of GABAergic interneurons or very intense discharges in the thalamus or by means of the activation of a neurogliaform interneurons in the cortex. The main receptor subunits GABA_B_1a, GABA_B_1b and GABA_B₂ are strongly expressed in neurons and glial cells throughout the central nervous system and GABA_B-R activation is related to many neuronal processes such as the modulation of rhythmic activity in several brain regions. In the thalamus, GABA_B-Rs modulate the generation of the main thalamic rhythm, spindle waves. In the cerebral cortex, GABA_B-Rs also modulate the most prominent emergent oscillatory activity—slow oscillations—as well as faster oscillations like gamma frequency. Further, recent studies evaluating the complexity expressed by the cortical network, a parameter associated with consciousness levels, have found that GABA_B-Rs enhance this complexity, while their blockade decreases it. This review summarizes the current results on how the activation of GABA_B-Rs affects the interchange of information between brain areas by controlling rhythmicity as well as synaptic plasticity.
Intracellular calcium chelation with BAPTA-AM modulates ethanol-induced behavioral effects in mice
2012, Experimental Neurology
Calcium (Ca²⁺) has been characterized as one of the most ubiquitous, universal and versatile intracellular signaling molecules responsible for controlling numerous cellular processes. Ethanol-induced effects on Ca²⁺ distribution and flux have been widely studied in vitro, showing that acute ethanol administration can modulate intracellular Ca²⁺ concentrations in a dose dependent manner. In vivo, the relationship between Ca²⁺ manipulation and the corresponding ethanol-induced behavioral effects have focused on Ca²⁺ flux through voltage-gated Ca²⁺ channels. The present study investigated the role of inward Ca²⁺ currents in ethanol-induced psychomotor effects (stimulation and sedation) and ethanol intake. We studied the effects of the fast Ca²⁺ chelator, BAPTA-AM, on ethanol-induced locomotor activity and the sedative effects of ethanol. Swiss (RjOrl) mice were pretreated with BAPTA-AM (0–10 mg/kg) 30 min before an ethanol (0–4 g/kg) challenge. Our results revealed that pretreatment with BAPTA-AM prevented locomotor stimulation produced by ethanol without altering basal locomotion. In contrast, BAPTA-AM reversed ethanol-induced hypnotic effects. In a second set of experiments, we investigated the effects of intracellular Ca²⁺ chelation on ethanol intake. Following a drinking-in-the-dark methodology, male C57BL/6J mice were offered 20% v/v ethanol, tap water, or 0.1% sweetened water. The results of these experiments revealed that BAPTA-AM pretreatment (0–5 mg/kg) reduced ethanol consumption in a dose-dependent manner while leaving water and sweetened water intake unaffected. Our findings support the role of inward Ca²⁺ currents in mediating different behavioral responses induced by ethanol. Our results are discussed together with data indicating that ethanol appears to be more sensitive to intracellular Ca²⁺ manipulations than other psychoactive drugs.
Baclofen in cannabis dependence syndrome
2010, Biological Psychiatry
GABA <inf>B</inf> receptor coupling to G-proteins and ion channels
2010, Advances in Pharmacology
Citation Excerpt :
The T-type CaV channels are low-voltage-activated, predominantly performing a pacemaker role; the other subtypes are high-voltage-activated. The GABAB receptor has been shown to couple specifically to the high-voltage-activated P-, Q-, and N- but not L- or R-type CaV channels (Guyon & Leresche, 1995; Harayama et al., 1998; Huston et al., 1995; Li & Stern, 2004; Mintz & Bean, 1993; Vigot et al., 2006). The electrophysiological relationship of GABAB-CaV has been extensively studied throughout the brain including the hippocampus (Doze et al., 1995; Wu & Saggau, 1995), SON (Li & Stern, 2004), DRG (Menon-Johansson et al., 1993), and midbrain (Cardozo & Bean, 1995).
GABA_B receptors have been found to play a key role in regulating membrane excitability and synaptic transmission in the brain. The GABA_B receptor is a G-protein coupled receptor (GPCR) that associates with a subset of G-proteins (pertussis toxin sensitive Gi/o family), that in turn regulate specific ion channels and trigger cAMP cascades. In this review, we describe the relationships between the GABA_B receptor, its effectors and associated proteins that mediate GABA_B receptor function within the brain. We discuss a unique feature of the GABA_B receptor, the requirement for heterodimerization to produce functional receptors, as well as an increasing body of evidence that suggests GABA_B receptors comprise a macromolecular signaling heterocomplex, critical for efficient targeting and function of the receptors. Within this complex, GABA_B receptors associate specifically with Gi/o G-proteins that regulate voltage-gated Ca²⁺ (Ca_V) channels, G-protein activated inwardly rectifying K⁺ (GIRK) channels, and adenylyl cyclase. Numerous studies have revealed that lipid rafts, scaffold proteins, targeting motifs in the receptor, and regulators of G-protein signaling (RGS) proteins also contribute to the function of GABA_B receptors and affect cellular processes such as receptor trafficking and activity-dependent desensitization. This complex regulation of GABA_B receptors in the brain may provide opportunities for new ways to regulate GABA-dependent inhibition in normal and diseased states of the nervous system.
Ischaemia differentially regulates GABA<inf>B</inf> receptor subunits in organotypic hippocampal slice cultures
2009, Neuropharmacology
Citation Excerpt :
For example, activation of presynaptic GABAB receptors that can down-regulate glutamate release might provide a mechanism to counteract excitotoxic neuronal cell death. The GABAB receptor agonist baclofen inhibits glutamate release (Huston et al., 1995) and has been reported to be neuroprotective in vivo (Babcock et al., 2002; Jackson-Friedman et al., 1997; Lal et al., 1995; Ouyang et al., 2007) and in organotypic hippocampal slice cultures during oxygen–glucose deprivation (OGD) (Dave et al., 2005). It has also been reported that both GABAA and GABAB receptor agonists can protect neurons against death induced by ischaemia/reperfusion in vivo via a mechanism involving inhibition of NMDA receptor-mediated nitric oxide (NO) production by neuronal NO synthase (nNOS) (Zhou et al., 2008).
Reduced synaptic inhibition due to dysfunction of ionotropic GABA_A receptors has been proposed as one factor in cerebral ischaemia-induced excitotoxic cell death. However, the participation of the inhibitory metabotropic GABA_B receptors in these pathological processes has not been extensively investigated. We used oxygen–glucose deprivation (OGD) and NMDA-induced excitotoxicity as models to investigate whether ischaemia-like challenges alter the protein levels of GABA_B1 and GABA_B2 receptor subunits in rat organotypic hippocampal slice cultures. Twenty-four hours after the insult both OGD and NMDA produced a marked decrease in the total levels of GABA_B2 (∼75%), while there was no significant change in the levels of GABA_B1 after OGD, but an increase after NMDA treatment (∼100%). The GABA_B receptor agonist baclofen (100 μM) was neuroprotective following OGD or NMDA treatment if added before or during the insult. GABA_B receptors comprise heterodimers of GABA_B1 and GABA_B2 subunits and our results suggest that the separate subunits are independently regulated in response to extreme neuronal stress. However, because GABA_B2 is required for functional surface expression, down-regulation of this subunit removes an important inhibitory feedback mechanism under pathological conditions.

View all citing articles on Scopus

View full text

The involvement of multiple calcium channel sub-types in glutamate release from cerebellar granule cells and its modulation by GABAB receptor activation

Abstract

Biochem. biophys. Res. Commun.

Eur. J. Pharmac.

Neurosci. Lett.

J. biol. Chem.

Biochem. Pharmac.

Neurosci. Lett.

Neuron

Neuroscience

Neuroscience

Neurosci. Res.

Neuron

Neuroscience

Prog. Neurobiol.

Neuron

Neuron

Trends pharmac. Sci.

Neuropharmacology

Neuron

Neuropharmacology

Biochim. biophys. Acta

Neuron

Neuron

Neurochem. Int.

Neuropharmacology

Neuropharmacology

Non-vesicular release of neurotransmitter

Neuron

A low voltage-activated, fully inactivating Ca2+ channel in vertebrate sensory neurones

Nature

Properties of a high voltage activated Ca2+ current in rat cerebellar granule cells

Eur. J. Neurosci.

Pertussis toxin reverses adenosine inhibition of neuronal glutamate release

Nature

Modulation of voltage dependent calcium channels by GABAB receptors and G proteins in cultured rat dorsal root ganglion neurons: relevance to transmitter release and its modulation

Voltage-dependent calcium channels and their modulation by neurotransmitters and G-proteins

Expl Physiol.

Glutamate, a neurotransmitter in mammalian brain

J. Neurochem.

The involvement of multiple calcium channel sub-types in glutamate release from cerebellar granule cells and its modulation by GABA_B receptor activation

A low voltage-activated, fully inactivating Ca²⁺ channel in vertebrate sensory neurones

Properties of a high voltage activated Ca²⁺ current in rat cerebellar granule cells

Modulation of voltage dependent calcium channels by GABA_B receptors and G proteins in cultured rat dorsal root ganglion neurons: relevance to transmitter release and its modulation